Free tool
FAERS Monitor: Dextrose 20% In Plastic Container
Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018564 or its brand name (Dextrose 20% In Plastic Container, Dextrose). Reports on generic versions are filed under their own applications.
Reports
13,727
Serious
12,671
92% of reports
Hospitalization
6,874
Death reported
2,102
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- myelosuppression1,855
- off label use1,091
- nausea1,037
- drug ineffective973
- vomiting963
- acute kidney injury807
- pyrexia731
- white blood cell count decreased714
- dyspnoea683
- sepsis588
- abdominal pain544
- hypotension532
- neutrophil count decreased496
- condition aggravated494
- anaemia486
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 53 |
| 2005 | 36 |
| 2006 | 49 |
| 2007 | 40 |
| 2008 | 64 |
| 2009 | 83 |
| 2010 | 117 |
| 2011 | 145 |
| 2012 | 148 |
| 2013 | 128 |
| 2014 | 395 |
| 2015 | 199 |
| 2016 | 312 |
| 2017 | 284 |
| 2018 | 380 |
| 2019 | 487 |
| 2020 | 611 |
| 2021 | 962 |
| 2022 | 1,571 |
| 2023 | 2,020 |
| 2024 | 1,949 |
| 2025 | 1,980 |
| 2026 | 1,712 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,432 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| myelosuppressionSignal | 1,855 | 83.1 | 79.6 | 142,958 |
| neutrophil count decreasedSignal | 496 | 18.9 | 17.3 | 8,287 |
| white blood cell count decreasedSignal | 714 | 10.2 | 9.5 | 5,874 |
| acute kidney injurySignal | 807 | 8.1 | 7.6 | 5,039 |
| sepsisSignal | 588 | 8.1 | 7.5 | 3,661 |
| hypotensionSignal | 532 | 4.1 | 3.7 | 1,238 |
| anaemiaSignal | 486 | 3.9 | 3.6 | 1,057 |
| abdominal painSignal | 544 | 3.6 | 3.3 | 1,022 |
| pyrexiaSignal | 731 | 3.2 | 3.0 | 1,147 |
| vomitingSignal | 963 | 3.1 | 3.0 | 1,434 |
| condition aggravatedSignal | 494 | 2.5 | 2.3 | 446 |
| nauseaSignal | 1,037 | 2.0 | 1.9 | 544 |
| off label use | 1,091 | 1.9 | 1.8 | 492 |
| dyspnoea | 683 | 1.8 | 1.7 | 273 |
| drug ineffective | 973 | 1.1 | 1.1 | 16 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.